|
Age/sex | Onset after initial GPA symptoms | cANCA | Biopsy status | Other organ systems involved | Management | Outcome | Reference |
|
30/M | 3-4 months | Positive | Skin: nonspecific chronic inflammation Renal: segmental necrotizing GN | Sinusitis, epistaxis, arthralgias, painless oral ulcers, active urine sediment, mild renal insufficiency (creat. 2.3 mg/dL), and left upper lung lobe fibrotic infiltrates | Cyclophosphamide and steroids | Gangrene formation with autoamputation | Handa and Wali [7]
|
|
80/M | 1-2 years | Positive | Skin: leukocytoclastic vasculitis | Multiple lung opacities with incomplete cavitation, renal insufficiency (creat. 1.5 mg/dL), microscopic hematuria, sensorineural hearing loss, and nasal ulcers | Cyclophosphamide and steroids | Gangrene formation, improvement of reversible tissue ischemia | La Civita et al. [8] |
|
68/M | 2 years | Not available | Sural nerve: vasculitis with secondary demyelination Lung: nodular necrotizing granulomatous inflammation with vasculitis | Purulent sinusitis, renal insufficiency (creat. 1.7 mg/dL), right peroneal neuropathy, otitis media, right 7th nerve palsy, pulmonary nodules, left pleural effusion, and pyoderma gangrenosum | Cyclophosphamide and steroids | Gangrene formation with surgical debridement and amputation | Phillips and Twiest [9] |
|
26/F | 1-2 years | Positive | Renal: focal crescentic GN Nasopharyngeal: small artery vasculitis | Secretory otitis, conjunctivitis, tonsillitis, arthritis, hematuria, mild renal insufficiency, mucosal ulcerations, and palpable purpura | Not specified | Gangrene formation | Karjalainen and Hakala [10] |
|
48/M | 3 months | Positive | Renal: pauci immune GN | Acute kidney injury (creat. 4.6 mg/dL), nasal crusting, hemoptysis, right sided pleuritic chest pain, and active urine sediment | Cyclophosphamide, steroids, heparin, aspirin, calcium channel blockers, nitroglycerin ointment, and plasmapheresis | Gangrene formation with autoamputation | Lim et al. [11] |
|
24/F | On presentation | Positive | Femoral artery: normal | Pulmonary infiltrates, splenic infarcts, hemoptysis, and nodular masses in bilateral lungs with diffuse interstitial lung disease | Cyclophosphamide, steroids, heparin, and thrombectomy | Gangrene formation with surgical amputation | Bessias et al. [12] |
|
55/M | 3-4 months | Negative | Nasopharyngeal: epithelial ulceration with vasculitis | Epistaxis, polyarthralgia, bilateral lung nodular densities with cavitations, and small pleural effusion | Cyclophosphamide, steroids, warfarin, thrombectomy, and bypass | Improvement of reversible tissue ischemia | Maia et al. [13] |
|
58/M | Unclear | Not available | Renal: 30% crescents | ENT, sinusitis, bronchiectasis, lung infiltrates, renal insufficiency (creat. 4.7 mg/dL), eye, and joint pain | Immunosuppression (not specified) | Gangrene formation | Pinching et al. [14] |
|
40/M | Unclear | Not available | Renal: granuloma and vasculitis with 30% crescents Respiratory tract: vasculitis | ENT, lung infiltrates, renal failure requiring hemodialysis (creat. 18.43 mg/dL), joint pain, eye, vasculitic skin rash, and mononeuritis multiplex | Immunosuppression (not specified) | Gangrene formation | Pinching et al. [14] |
|
39/F | On presentation | Positive | Lung: patchy nodular fibrotic changes with hemosiderin laden macrophages and diffuse alveolar hemorrhage Left 4th gangrene digit: vasculitic changes with no thrombotic phenomenon | Hemoptysis, decline in respiratory function, and bilateral pulmonary infiltrates | Cyclophosphamide, steroids, and plasmapheresis | Gangrene formation with surgical amputation, improvement of reversible tissue ischemia | Leung et al. [15] |
|
45/M | 2 years | Positive | Renal: necrotizing GN | Polyneuropathy, renal injury, arthralgia, mild bloody nasal discharge, and skin vasculitis | Cyclophosphamide, steroids, heparin, aspirin, and iloprost | Improvement of reversible tissue ischemia | Schmidt et al. [16] |
|
41/M | 2 years | Positive | Sinus: granulomatous vasculitis | Bloody nasal discharge, inner ear granuloma, polyneuropathy, pulmonary infiltrates, and destructive sinusitis | Cyclophosphamide, steroids, heparin, aspirin, and iloprost | Improvement of reversible tissue ischemia | Schmidt et al. [16] |
|
49/M | On presentation | Positive | Sural nerve: axonal loss | Mononeuritis multiplex with left foot drop, and cavitary nodule in the lung | Cyclophosphamide, steroids | Acroosteolysis, improvement of reversible ischemia | Modi et al. [17] |
|
61/F | 4 months | Positive | Renal: focal segmental necrotizing GN | Joint pain, Raynaud’s, and acute kidney injury | Cyclophosphamide, steroids | Gangrene formation with autoamputation | Bartsch et al. [18] |
|
46/F | 2 months | Positive | Skin: leukocytoclastic vasculitis | Polyarthralgias, epistaxis, sinusitis, mouth ulcers, episcleritis, mononeuritis multiplex, multiple nodules in right lung, and active urine sediment | Cyclophosphamide, steroids, and iloprost | Gangrene formation | Kejriwal et al. [19] |
|
26/M | On presentation | Positive | Skin: superficial dermal blood vessel necrosis | Oligoarthritis, polydipsia, polyuria, lung nodules, and mucosal thickening of maxillary sinus | Cyclophosphamide, steroids, and azathioprine | Gangrene formation with autoamputation | Agarwal and Khan [20] |
|
62/M | On presentation | Positive | | Nasal ulceration and congestion, epistaxis, episcleritis, hemoptysis, diffuse alveolar hemorrhage, pulmonary infiltrates, joint pain, renal insufficiency (creat. 1.7), and active urine sediment | Cyclophosphamide, steroids | Improvement of reversible ischemia, gangrene formation with autoamputation | Current case |
|